DNA · Ginkgo Bioworks Holdings, Inc.
$6.79
-0.45 (-6.22%)
At close · Aug 14
Market Cap
$457.24M
Shares
67.34M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jason Kelly | Chief Executive Officer | $5,709,049 |
| Reshma Shetty | President & Former Chief Operating Officer | $3,479,364 |
| Steven Coen | Chief Financial Officer | $1,332,326 |
| Mark Dmytruk | Former Chief Financial Officer | $386,941 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mark Dmytruk | Chief Financial Officer | $1,780,000 |
| Reshma Shetty | President & Chief Operating Officer | $1,231,000 |
| Jason Kelly | Chief Executive Officer | $1,231,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mark Dmytruk | Chief Financial Officer | $1,694,500 |
| Jason Kelly | Chief Executive Officer | $262,019 |
| Reshma Shetty | President & Chief Operating Officer | $262,019 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mark Dmytruk | Chief Financial Officer | $2,195,450 |
| Reshma Shetty | President & Chief Operating Officer | $262,500 |
| Jason Kelly | Chief Executive Officer | $262,500 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jason Kelly | Chief Executive Officer | $380,742,276 |
| Reshma Shetty | President & Chief Operating Officer | $380,742,276 |
| Mark Dmytruk | Chief Financial Officer | $40,068,678 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Reshma Shetty | President & Chief Operating Officer | $10,533,733 |
| Jason Kelly | Chief Executive Officer | $10,533,188 |
| Mark Dmytruk | Chief Financial Officer | $66,611 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mark Dmytruk | Chief Financial Officer and principal financial officer | Resigned | 2025-05-21 |
| Dr. Arie Belldegrun | director | Resigned | 2024-11-12 |
| Dr. Sri Kosuri | Class B director | Appointed | 2024-11-12 |
| Steven P. Coen | Chief Accounting Officer | Appointed | 2023-05-05 |
| Marie E. Fallon | Chief Accounting Officer | Resigned | 2023-05-05 |
| Kathy Hopinkah Hannan | Director | Appointed | 2022-08-04 |
Key facts
CIK
1830214
CUSIP
37611X209
13F (30d)
184 filings
174 filers
Visit website
Investor relations